Loading...
Keywords
Last Name
Institution

Connection

Tarak Srivastava to Parathyroid Hormone

This is a "connection" page, showing publications Tarak Srivastava has written about Parathyroid Hormone.

 
Connection Strength
 
 
 
0.976
 
  1. Srivastava T, Garg U, Ruiz M, Dai H, Alon US. Serum 25(OH)-vitamin D level in children: is there a need to change the reference range based on 2011 Institute of Medicine report? Clin Pediatr (Phila). 2013 Feb; 52(2):178-82.
    View in: PubMed
    Score: 0.405
  2. VanSickle JS, Srivastava T, Alon US. Use of calcimimetics in children with normal kidney function. Pediatr Nephrol. 2019 03; 34(3):413-422.
    View in: PubMed
    Score: 0.157
  3. Srivastava T, Jafri S, Truog WE, Sebestyen VanSickle J, Manimtim WM, Alon US. Successful Reversal of Furosemide-Induced Secondary Hyperparathyroidism With Cinacalcet. Pediatrics. 2017 Dec; 140(6).
    View in: PubMed
    Score: 0.154
  4. Srivastava T, Krudys J, Mardis NJ, Sebestyen-VanSickle J, Alon US. Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b. Pediatr Nephrol. 2016 May; 31(5):795-800.
    View in: PubMed
    Score: 0.134
  5. Srivastava T, Alon US. Pathophysiology of hypercalciuria in children. Pediatr Nephrol. 2007 Oct; 22(10):1659-73.
    View in: PubMed
    Score: 0.074
  6. Srivastava T, Alon US. Stage I vitamin D-deficiency rickets mimicking pseudohypoparathyroidism type II. Clin Pediatr (Phila). 2002 May; 41(4):263-8.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.